drug

LY03017

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Luye Pharma Group Ltd.
3 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

3
Effect of Food and Age on the Pharmacokinetics of LY03017
NCT06793995Phase 1Not Yet Recruiting
A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017
NCT06980207Phase 1Not Yet Recruiting
A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017
NCT06388551Phase 1Unknown

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Luye Pharma Group Ltd.
company
trial
Effect of Food and Age on the Pharmacokinetics of LY03017
PHASE1
trial
A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017
PHASE1
trial
A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017
PHASE1
trial
indication
Hallucinations and Delusions Associated With Parkinson Disease Psychosis
indication
Hallucinations
indication
Parkinson Disease Psychosis
indication
Negative Symptoms of Schizophrenia
indication